Venture Capital
MINNEAPOLIS, July 15, 2019-- POPS! Diabetes Care—a revolutionary diabetes care management company—is excited to announce that it has closed an oversubscribed Series A funding round of $6 million USD due to strong investor demand. 30Ventures, a healthcare and biotechnology venture capital firm focused on investing in innovative companies that drive down healthcare costs and improve patient outcomes, led the round. George Arida, 30Ventures’ Managing Partner, also joins the POPS! board. Revolution’s Rise of the Rest Seed Fund and Flying Point Industries also participated in the round.

In this article